REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $384,451 | -54.1% | 33,518 | +1.2% | 0.00% | -100.0% |
| Q2 2023 | $838,394 | -14.7% | 33,125 | +8.5% | 0.00% | 0.0% |
| Q1 2023 | $983,114 | +74.5% | 30,522 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $563,436 | -24.8% | 30,522 | +10.0% | 0.00% | 0.0% |
| Q3 2022 | $749,169 | +99.8% | 27,747 | +2.2% | 0.00% | 0.0% |
| Q2 2022 | $375,000 | -30.7% | 27,154 | -2.1% | 0.00% | 0.0% |
| Q1 2022 | $541,000 | +19.4% | 27,745 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $453,000 | -40.7% | 27,745 | +1.2% | 0.00% | -50.0% |
| Q3 2021 | $764,000 | -6.0% | 27,418 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $813,000 | +5.0% | 27,418 | -1.0% | 0.00% | 0.0% |
| Q1 2021 | $774,000 | -1.1% | 27,689 | +0.2% | 0.00% | 0.0% |
| Q4 2020 | $783,000 | +48.3% | 27,629 | +31.5% | 0.00% | +100.0% |
| Q3 2020 | $528,000 | +7.8% | 21,010 | +4.7% | 0.00% | 0.0% |
| Q2 2020 | $490,000 | +32.1% | 20,064 | -20.0% | 0.00% | 0.0% |
| Q1 2020 | $371,000 | +4.8% | 25,091 | +14.9% | 0.00% | 0.0% |
| Q4 2019 | $354,000 | +64.7% | 21,838 | +32.3% | 0.00% | – |
| Q3 2019 | $215,000 | +4.9% | 16,508 | +4.6% | 0.00% | – |
| Q2 2019 | $205,000 | -4.2% | 15,775 | +15.9% | 0.00% | – |
| Q1 2019 | $214,000 | -21.9% | 13,606 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $274,000 | -11.3% | 13,606 | +9.4% | 0.00% | 0.0% |
| Q3 2018 | $309,000 | -9.4% | 12,433 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $341,000 | +6.6% | 12,433 | +19.6% | 0.00% | 0.0% |
| Q1 2018 | $320,000 | -14.0% | 10,392 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $372,000 | +30.1% | 10,392 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $286,000 | +4.4% | 10,392 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $274,000 | +35.6% | 10,392 | +75.5% | 0.00% | – |
| Q4 2015 | $202,000 | -16.5% | 5,920 | -21.9% | 0.00% | -100.0% |
| Q2 2015 | $242,000 | – | 7,579 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |